Expanded newborn screening: Outcome in screened and unscreened patients at age 6 years

Pediatrics

Volumn 124, Issue 2, 2009, Pages

  Wilcken, Bridget ^a,b   Haas, Marion ^c   Joy, Pamela ^a,d   Wiley, Veronica ^a,b   Bowling, Francis ^e,f   Carpenter, Kevin ^a,b   Christodoulou, John ^a,b   Cowley, David ^e,f   Ellaway, Carolyn ^a,b   Fletcher, Janice ^g,h   Kirk, Edwin P ^i,j   Lewis, Barry ^k   McGill, Jim ^f,l   Peters, Heidi ^m,n   Pitt, James ^m,n   Ranieri, Enzo ^g   Yaplito Lee, Joy ^m   Boneh, Avihu ^m,n  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^d MACQUARIE UNIVERSITY   (Australia)

^e MATER HOSPITAL   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^h UNIVERSITY OF ADELAIDE   (Australia)

ⁱ SYDNEY CHILDREN'S HOSPITAL   (Australia)

^j UNIVERSITY OF NEW SOUTH WALES   (Australia)

^k PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^l ROYAL CHILDREN'S HOSPITAL   (Australia)

^m ROYAL CHILDREN'S HOSPITAL   (Australia)

ⁿ UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

Health care; Neonatal screening; Outcome assessment; Tandem mass spectrometry

Indexed keywords

MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE;

ARTICLE; AUSTRALIA; CHILD; CHILD GROWTH; CONTROLLED STUDY; DIET; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; ENZYME DEFICIENCY; FATTY ACID METABOLISM; HUMAN; INBORN ERROR OF METABOLISM; INFANT; INTELLECT; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; NEWBORN SCREENING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; TANDEM MASS SPECTROMETRY;

ACYL-COA DEHYDROGENASE; AUSTRALIA; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; METABOLISM, INBORN ERRORS; NEONATAL SCREENING; PREDICTIVE VALUE OF TESTS; TANDEM MASS SPECTROMETRY;

EID: 67749135437     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-0586     Document Type: Article

References (24)

1. Schulze A, Lindner M, Kohlmüller D, et al. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics. 2003;111(6 pt 1):1399-1406
2. Waisbren SE, Albers S, Amato S. Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA. 2003;290(19):2564-2572
3. Nennstiel-Ratzel U, Arenz S, Maier EM, et al. Reduced incidence of severe metabolic crisis or death in children with medium-chain acyl-CoA dehydrogenase deficiency homozygous for c. 985A>G identified by neonatal screening. Mol Genet Metab. 2005;85(2):157-159
4. Wilcken B, Haas M, Joy P, et al. Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study. Lancet. 2007;369(9555):37-42
5. Simon E, Fingerhut R, Baumkötter J, Konstantopoulou V, Ratschmann R, Wendel U. Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease. J Inherit Metab Dis. 2006;29(4):527-532
6. Strauss KA, Puffenberger EG, Robinson DL, Morton DH. Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet. 2003;121C(1):38 -52
7. Kölker S, Garbade SF, Boy N, et al. Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany. Pediatr Res. 2007;62(3):357-363
8. Boneh A, Beauchamp M, Humphrey M, Watkins J, Peters H, Yaplito-Lee J. Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome. Mol Genet Metab. 2008;94(3):287-291
9. Bijarnia S, Wiley V, Carpenter K, Christodoulou J, Ellaway CJ, Wilcken B. Glutaric aciduria type I: outcome following detection by newborn screening. J Inherit Metab Dis. 2008;31(4):503-507
10. Frazier DM, Millington DS, McCandless SE, et al. The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis. 2006;29(1):76-85
11. Norman R, Haas M, Wilcken B. International perspectives on the cost-effectiveness of tandem mass spectrometry for rare metabolic conditions. Health Policy. 2009;89(3):252-260
12. Wiley V, Carpenter K, Wilcken B. Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia. Acta Paediatr Suppl. 1999;88(432):48-51
13. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data. 2000;(314):1-27
14. Stadler SC, Polanetz R, Maier EM, et al. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment. Hum Mutat. 2006;27(8):748-759
15. Ly TB, Peters V, Gibson KM, et al. Mutations in the AUH gene cause 3-methylglutaconic aciduria type I. Hum Mutat. 2003;21(4):401-407
16. Jethva R, Bennett MJ, Vockley J. Short-chain acyl-coenzyme A dehydrogenase deficiency. Mol Genet Metab. 2008;95(4):195-200
17. Wilcken B, Wiley V, Hammond J, Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med. 2003;348(23):2304-2312
18. Bhattacharya K, Khalili V, Wiley V, Carpenter K, Wilcken B. Newborn screening may fail to identify intermediate forms of maple syrup urine disease. J Inherit Metab Dis. 2006;29(4):586
19. Häberle J, Pauli S, Schmidt E, Schulze-Eilfing B, Berning C, Koch HG. Mild citrullinemia in Caucasians is an allelic variant of argininosuccinate synthetase deficiency (citrullinemia type 1). Mol Genet Metab. 2003;80(3):302-306
20. Ensenauer R, Vockley J, Willard JM, et al. A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. Am J Hum Genet. 2004;75(6):1136-1142
21. American College of Medical Genetics Newborn Screening Expert Group. Newborn screening: toward a uniform screening panel and system - executive summary. Pediatrics. 2006;117(5 pt 2):S296-S307
22. Pollitt RJ. International perspectives on newborn screening. J Inherit Metab Dis. 2006;29(2-3): 390-396
23. Norman R, Haas M, Chaplin M, Joy P, Wilcken B. Economic evaluation of tandem mass spectrometry newborn screening in Australia. Pediatrics. 2009;123(2):451-457
24. Rinaldo P, Zafari S, Tortorelli S, Matern D. Making the case for objective performance metrics in newborn screening by tandem mass spectrometry. Ment Retard Dev Disabil Res Rev. 2006;12(4): 255-261